---
document_datetime: 2023-09-21 17:12:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/oxervate-epar-all-authorised-presentations_en.pdf
document_name: oxervate-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7499305
conversion_datetime: 2025-12-19 00:09:19.232091
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented)   | Strength   | Pharmaceutical      | Route of       | Immediate    | Content         | Pack size          |
|------------------|--------------|------------|---------------------|----------------|--------------|-----------------|--------------------|
|                  | name         |            | Form                | Administration | Packaging    | (concentration) |                    |
| EU/1/17/1197/001 | Oxervate     | 20 Âµg/ml   | Eye drops, solution | Ocular use     | vial (glass) | 1 ml            | 7 multi-dose vials |